T he use of ventricular assist devices (VADs) in the pediatric population continues to gain interest among clinicians as an alternative to extracorporeal membrane oxygenation (ECMO) for temporary circulatory support (TCS). In the pediatric population, extracorporeal membrane oxygenation (ECMO) has been the traditional method of TCS whereas durable VADs have been reserved for longer-term support. The interest in the use of temporary VAD support in pediatrics has grown likely from the ability to evaluate for recovery, assess the neurologic status and potential for decreased complications, and determine treatment options without the time constraints of ECMO. Despite the potential advantages, the use of TCS with VAD has lagged behind the use of long-term VADs, likely a reflection of the limited published experience of single case reports or small case series (1–3) and the need for central cannulation for most of the devices in pediatrics. For these reasons, further studies reporting the outcomes of TCS with VAD compared with ECMO are important to determine the optimal treatment strategy.

中文翻译：

---

扩大临时心室辅助装置在儿科患者中的使用

在儿科人群中使用心室辅助装置 (VAD) 作为临时循环支持 (TCS) 的体外膜肺氧合 (ECMO) 的替代方案继续引起临床医生的兴趣。在儿科人群中，体外膜肺氧合 (ECMO) 一直是 TCS 的传统方法，而耐用的 VAD 已被保留用于长期支持。在儿科中使用临时 VAD 支持的兴趣可能来自于评估恢复的能力、评估神经系统状态和减少并发症的可能性，以及在没有 ECMO 时间限制的情况下确定治疗方案。尽管具有潜在优势，但 TCS 与 VAD 的使用落后于长期 VAD 的使用，可能反映了单个病例报告或小病例系列 (1-3) 的有限发表经验以及大多数儿科器械需要中央插管。由于这些原因，报告 TCS 与 VAD 与 ECMO 相比的结果的进一步研究对于确定最佳治疗策略很重要。